IGC Pharma, Inc.

NYSEAM:IGC Stock Report

Market Cap: US$23.8m

IGC Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:IGC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Sep 24BuyUS$200,000James MoranIndividual588,235US$0.34

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IGC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders8,493,66810.7%
Institutions16,682,94220.9%
General Public54,508,55568.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 31.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.4%
Bradbury Fund Management Limited
13,823,529US$4.1m0%7.49%
6.15%
Ram Mukunda
4,903,430US$1.5m12.6%no data
1.6%
Richard Prins
1,271,251US$380.1k21.9%no data
1.49%
Claudia Grimaldi
1,184,252US$354.1k14.2%no data
1.39%
James Moran
1,105,735US$330.6k17.3%no data
0.88%
BlackRock, Inc.
703,798US$210.4k0%no data
0.88%
Geode Capital Management, LLC
700,014US$209.3k4.53%no data
0.81%
The Vanguard Group, Inc.
645,166US$192.9k0%no data
0.21%
State Street Global Advisors, Inc.
165,307US$49.4k0%no data
0.18%
Squarepoint OPS LLC
140,510US$42.0k11.6%no data
0.14%
Northern Trust Global Investments
113,407US$33.9k0%no data
0.12%
Citadel Advisors LLC
94,471US$28.2k2,980%no data
0.11%
Dearborn Partners L.L.C.
84,401US$25.2k-22.9%no data
0.082%
Goldman Sachs Group, Investment Banking and Securities Investments
65,541US$19.6k0%no data
0.046%
BB&T Trust
36,667US$11.0k0%no data
0.043%
Commonwealth Equity Services, LLC
34,600US$10.3k0%no data
0.04%
XTX Holdings Limited, Asset Management Arm
32,083US$9.6k0%no data
0.036%
Terry Lierman
29,000US$8.7k0%no data
0.022%
Morgan Stanley, Investment Banking and Brokerage Investments
17,707US$5.3k0%no data
0.017%
Tower Research Capital Europe Limited
13,353US$4.0k20.9%no data
0.009%
Group One Trading LP, Asset Management Arm
7,187US$2.1k-31.1%no data
0.0038%
Geneos Wealth Management, Inc., Asset Management Arm
3,000US$895.90%no data
0.00089%
Simplex Trading, LLC, Asset Management Arm
712US$212.1-21.9%no data
0.00082%
CIBC Private Wealth Advisors, Inc.
655US$195.40%no data
0.00076%
Bank of America Corporation, Asset Management Arm
604US$181.15.41%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/20 16:41
End of Day Share Price 2025/06/18 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IGC Pharma, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Edward WooAscendiant Capital Markets LLC
Aditya KhandekarRedChip Companies, Inc.